After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership ...

An audit found that a USC office had over a million in “questionable transactions.” Now its director is running the SC ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

Jennifer Kingston was awarded the Royal Society of Chemistry's Technical Excellence Prize, which honours the vital role of ...

Quanterix Corporation ("Quanterix" or the "Company") , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of ...

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to ...

However, there's one potentially lucrative growth opportunity that Pfizer's focusing on that could change things and ...

The global mesalamine market size was US$ 169.5 million in 2021. The global mesalamine market size is forecast to reach US$ 212.6 million by 2030, registering a compound annual growth rate (CAGR) of 3 ...

Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

AbbVie's Q1 2026 dividend increases 5.5% YOY, lagging both its past growth rates and the healthcare sector median. Learn more ...